Blue Copper 5 Intensive Ampoule — Clinical Results

Clinical Results

Blue Copper 5 Intensive Ampoule

A concentrated Blue Copper treatment built on Matrixyl® 3000, the matrikine peptide duo carried at its clinically studied dose. Here is the evidence behind the active.

The ingredient evidence

Matrikine peptide complex (Matrixyl® 3000)

Clinically dosed — an exact match to the studied level

A pairing of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 that signals the skin to rebuild its collagen scaffolding. The ampoule carries it at the same concentration used in the study below.

Clinical result vs placebo Figure
Surface area occupied by deep wrinkles (>200µm) -44.9%
Main wrinkle density -37.0%
Average wrinkle depth (4-month study) -27%
Skin tone +19.5%

Method: Supplier clinical studies of the peptide duo; half-face, placebo-controlled, twice daily (2-month and 4-month panels). Supplier study of the ingredient; not conducted on the finished Osmotics product.

Laboratory evidence

In-vitro, same dossier

In fibroblast cultures, the same peptide complex significantly increased synthesis of the skin’s core structural proteins.

Protein synthesis Increase
Collagen I +258%
Hyaluronic acid +179%
Fibronectin +164%

Method: In-vitro fibroblast culture study by the ingredient manufacturer. Laboratory results; not a measure of results on human skin.

Blue Copper peptide

Pioneered by Osmotics in 1998

Copper peptides are among the most-studied molecules in skin science, with peer-reviewed research since 1988 showing they stimulate collagen synthesis in fibroblasts.

References: Maquart et al., FEBS Letters, 1988.

Shop the Intensive Ampoule